Skip to search formSkip to main contentSkip to account menu

2,3-N-octanoylsphingosine

Known as: 2,3-N-octanoyl-D-erythro-trans-sphingosine, C8-ceramide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Resistance to chemotherapy and endocrine therapy is a major cause of breast cancer treatment failure. We have synthesized six… 
Highly Cited
2003
Highly Cited
2003
Lipopolysaccharide (LPS) and interferon‐γ (IFN) treatment of C6 rat glioma cells increased the intracellular ceramide level and… 
Highly Cited
2002
Highly Cited
2002
In analyzing the regulation of neurotrophin production/secretion from microglia, C8‐ceramide (d‐erythro‐sphingosine, N‐octanoyl… 
Highly Cited
1997
Highly Cited
1997
Increased sensitivity to ionizing radiation has been shown to be due to defects in double-strand break repair and mutations in… 
Highly Cited
1996
Highly Cited
1996
In the study of apoptosis initiated by various signals including ligands binding to cell membrane receptors such as Fas and TNFRI… 
Highly Cited
1996
Highly Cited
1996
Recent studies have demonstrated that ovarian follicle atresia occurs extensively before follicle selection into the avian… 
Highly Cited
1995
Highly Cited
1995
Ceramide and ceramide-1-phosphate are sphingolipid analogues of diacylglycerol and phosphatidate, respectively, and they are… 
Highly Cited
1993
Highly Cited
1993
Recent investigations suggest that tumor necrosis factor (TNF)-alpha may utilize the sphingomyelin pathway for signal…